Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2010
ISBN 10: 3838386205 ISBN 13: 9783838386201
Da: preigu, Osnabrück, Germania
EUR 43,35
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Biochemical effects of Streptokinase in Acute Myocardial Infarction | History of thrombolytic therapy and biochemical effects of Streptokinase | Julia Yeasmin | Taschenbuch | 80 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838386201 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Jul 2010, 2010
ISBN 10: 3838386205 ISBN 13: 9783838386201
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 49,00
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Thrombotic therapy is an important therapeutic intervention which is effective in reducing morbidity and mortality in different clinical situations. Streptokinase is the cheapest and most widely used thrombolytic agent. Hepatic and renal functions, CK-MB and thrombin clotting time were measured in 25 patients of Acute Myocardial Infarction given Streptokinase and 25 control patients of AMI not given Streptokinase. Administration of Streptokinase did not cause significant elevation of the biochemical parameters reflecting hepatic and renal functions. Prolongation of the thrombin clotting implies biochemical confirmation of thrombolysis. The thrombin clotting time was significantly increased with the administration of Streptokinase in this study thereby biochemically confirming that thrombolysis had occurred with use of Streptokinase. This book traces the discovery of thrombolytic therapy and its initiation into clinical use and discusses in detail the hazards of thrombolytic therapy. It will be of major use for cardiologists, biochemists and physicians involved in the management of acute coronary events with thrombolytic therapy. 80 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2010
ISBN 10: 3838386205 ISBN 13: 9783838386201
Da: moluna, Greven, Germania
EUR 41,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Yeasmin JuliaJulia Yeasmin: graduated (MBBS) from Dhaka Medical College, Dhaka University. Worked in different AIDS prevention projects. Obtained Ph.D in Biochemistry from Rajshahi University. Practising Physician and Biochemist in P.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Jul 2010, 2010
ISBN 10: 3838386205 ISBN 13: 9783838386201
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 49,00
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Thrombotic therapy is an important therapeutic intervention which is effective in reducing morbidity and mortality in different clinical situations. Streptokinase is the cheapest and most widely used thrombolytic agent. Hepatic and renal functions, CK-MB and thrombin clotting time were measured in 25 patients of Acute Myocardial Infarction given Streptokinase and 25 control patients of AMI not given Streptokinase. Administration of Streptokinase did not cause significant elevation of the biochemical parameters reflecting hepatic and renal functions. Prolongation of the thrombin clotting implies biochemical confirmation of thrombolysis. The thrombin clotting time was significantly increased with the administration of Streptokinase in this study thereby biochemically confirming that thrombolysis had occurred with use of Streptokinase. This book traces the discovery of thrombolytic therapy and its initiation into clinical use and discusses in detail the hazards of thrombolytic therapy. It will be of major use for cardiologists, biochemists and physicians involved in the management of acute coronary events with thrombolytic therapy.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 80 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2010
ISBN 10: 3838386205 ISBN 13: 9783838386201
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 49,59
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Thrombotic therapy is an important therapeutic intervention which is effective in reducing morbidity and mortality in different clinical situations. Streptokinase is the cheapest and most widely used thrombolytic agent. Hepatic and renal functions, CK-MB and thrombin clotting time were measured in 25 patients of Acute Myocardial Infarction given Streptokinase and 25 control patients of AMI not given Streptokinase. Administration of Streptokinase did not cause significant elevation of the biochemical parameters reflecting hepatic and renal functions. Prolongation of the thrombin clotting implies biochemical confirmation of thrombolysis. The thrombin clotting time was significantly increased with the administration of Streptokinase in this study thereby biochemically confirming that thrombolysis had occurred with use of Streptokinase. This book traces the discovery of thrombolytic therapy and its initiation into clinical use and discusses in detail the hazards of thrombolytic therapy. It will be of major use for cardiologists, biochemists and physicians involved in the management of acute coronary events with thrombolytic therapy.